GLEAMER on LinkedIn: OncoView selected as part of France 2030
Summary
\U0001f3c6 Gleamers "OncoView" Project Awarded in the "Digital Health" Category of the France 2030 Innovation Program \U0001f31f We are excited to share that "OncoView", our groundbreaking project to fight cancer, has been selected as part of the France 2030 program to drive innovation in digital health! This 18M investment into "OncoView" will be supported by a 4.5M co-financing from the French government - a major milestone in our mission to revolutionize oncology CT scan interpretation and cancer care with AI. \U0001f397 OncoView will be the first comprehensive AI solution for oncology CT scans, assisting radiologists in: \U0001f52c Screening \U0001fa7a Diagnosis \U0001f4ca Disease monitoring With OncoView, we are expanding the capabilities of the Gleamer Copilot\xae to fight cancer by: Enhancing diagnostic accuracy Providing reliable evaluations of treatment outcomes Personalizing care pathways to meet each patients unique needs This recognition is a testament to the incredible teamwork and shared vision at Gleamer. Together, were advancing the future of radiology and the fight against cancer. \U0001f310 For more details, check out our press release: In English: https://lnkd.in/epGCBJKY Or French: https://lnkd.in/eAAXj7Ud #AI #CancerCare #HealthcareInnovation #Radiology #France2030
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
